Rank | Gene Set | Z-score |
---|---|---|
1 | eosinophil chemotaxis (GO:0048245) | 8.08789037 |
2 | eosinophil migration (GO:0072677) | 7.10284534 |
3 | cellular response to ethanol (GO:0071361) | 5.84301920 |
4 | neutrophil activation involved in immune response (GO:0002283) | 5.68462905 |
5 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.63371537 |
6 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.63371537 |
7 | modulation by symbiont of host immune response (GO:0052553) | 5.63371537 |
8 | positive regulation by symbiont of host defense response (GO:0052509) | 5.63371537 |
9 | modulation by symbiont of host defense response (GO:0052031) | 5.63371537 |
10 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.63371537 |
11 | * monocyte chemotaxis (GO:0002548) | 5.04303758 |
12 | microglial cell activation (GO:0001774) | 4.64676118 |
13 | regulation of branching involved in salivary gland morphogenesis (GO:0060693) | 4.41415678 |
14 | glycosphingolipid catabolic process (GO:0046479) | 4.27309648 |
15 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 4.19781014 |
16 | positive regulation of lymphocyte migration (GO:2000403) | 4.08303613 |
17 | * regulation of lymphocyte chemotaxis (GO:1901623) | 4.08191417 |
18 | macrophage activation involved in immune response (GO:0002281) | 4.07421682 |
19 | pinocytosis (GO:0006907) | 3.97708637 |
20 | regulation of vitamin metabolic process (GO:0030656) | 3.94247857 |
21 | response to peptidoglycan (GO:0032494) | 3.92351811 |
22 | glycolipid catabolic process (GO:0019377) | 3.92032307 |
23 | positive regulation of macrophage differentiation (GO:0045651) | 3.90974614 |
24 | positive regulation of monocyte chemotaxis (GO:0090026) | 3.83872945 |
25 | oligosaccharide catabolic process (GO:0009313) | 3.81919382 |
26 | * regulation of mononuclear cell migration (GO:0071675) | 3.78593797 |
27 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.74507176 |
28 | regulation of chemokine biosynthetic process (GO:0045073) | 3.72423274 |
29 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 3.63599185 |
30 | macrophage activation (GO:0042116) | 3.62072816 |
31 | positive regulation of heat generation (GO:0031652) | 3.58545139 |
32 | * lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.56340771 |
33 | granulocyte activation (GO:0036230) | 3.54669067 |
34 | positive regulation of interferon-alpha production (GO:0032727) | 3.53646921 |
35 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 3.53048237 |
36 | regulation of fever generation (GO:0031620) | 3.48132758 |
37 | regulation of interferon-alpha production (GO:0032647) | 3.47839283 |
38 | response to muramyl dipeptide (GO:0032495) | 3.45827407 |
39 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 3.44910180 |
40 | * regulation of lymphocyte migration (GO:2000401) | 3.44890111 |
41 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 3.43220991 |
42 | NIK/NF-kappaB signaling (GO:0038061) | 3.40682726 |
43 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.40181791 |
44 | response to host immune response (GO:0052572) | 3.40181791 |
45 | cyclooxygenase pathway (GO:0019371) | 3.39348454 |
46 | ceramide catabolic process (GO:0046514) | 3.39063222 |
47 | regulation of monocyte chemotaxis (GO:0090025) | 3.39029787 |
48 | cellular response to zinc ion (GO:0071294) | 3.37578512 |
49 | decidualization (GO:0046697) | 3.37300154 |
50 | T-helper 1 type immune response (GO:0042088) | 3.33900447 |
51 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 3.28480871 |
52 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.28124933 |
53 | myeloid cell activation involved in immune response (GO:0002275) | 3.27290502 |
54 | membrane lipid catabolic process (GO:0046466) | 3.26408658 |
55 | neutrophil activation (GO:0042119) | 3.24571307 |
56 | myeloid dendritic cell differentiation (GO:0043011) | 3.23598450 |
57 | barbed-end actin filament capping (GO:0051016) | 3.23323484 |
58 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.22696977 |
59 | negative regulation of smooth muscle cell differentiation (GO:0051151) | 3.22610785 |
60 | phagocytosis, engulfment (GO:0006911) | 3.21588841 |
61 | regulation of cholesterol storage (GO:0010885) | 3.20490165 |
62 | * regulation of macrophage chemotaxis (GO:0010758) | 3.17193072 |
63 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 3.10743225 |
64 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 3.10338026 |
65 | ribosomal small subunit biogenesis (GO:0042274) | 3.10047829 |
66 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 3.09061792 |
67 | detection of molecule of bacterial origin (GO:0032490) | 3.08816809 |
68 | response to laminar fluid shear stress (GO:0034616) | 3.08539418 |
69 | positive regulation of type 2 immune response (GO:0002830) | 3.08119723 |
70 | * cellular response to lipopolysaccharide (GO:0071222) | 3.04569867 |
71 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.03743898 |
72 | * granulocyte chemotaxis (GO:0071621) | 3.02887450 |
73 | response to host (GO:0075136) | 3.02183121 |
74 | response to host defenses (GO:0052200) | 3.02183121 |
75 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.02183121 |
76 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.00439257 |
77 | respiratory burst (GO:0045730) | 2.98112796 |
78 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 2.97947472 |
79 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.97799454 |
80 | amino sugar catabolic process (GO:0046348) | 2.96899577 |
81 | positive regulation of acute inflammatory response (GO:0002675) | 2.96866961 |
82 | positive regulation of macrophage cytokine production (GO:0060907) | 2.96356268 |
83 | cellular response to cadmium ion (GO:0071276) | 2.96269005 |
84 | myeloid cell homeostasis (GO:0002262) | 2.95277452 |
85 | * cellular response to molecule of bacterial origin (GO:0071219) | 2.94120084 |
86 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.94035182 |
87 | positive regulation of macrophage derived foam cell differentiation (GO:0010744) | 2.93967259 |
88 | regulation of nitric oxide biosynthetic process (GO:0045428) | 2.93678299 |
89 | sphingolipid catabolic process (GO:0030149) | 2.93220956 |
90 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.92028776 |
91 | immunoglobulin mediated immune response (GO:0016064) | 2.91122522 |
92 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.90906094 |
93 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.87957588 |
94 | * granulocyte migration (GO:0097530) | 2.87850622 |
95 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.87766228 |
96 | adhesion of symbiont to host cell (GO:0044650) | 2.87227217 |
97 | virion attachment to host cell (GO:0019062) | 2.87227217 |
98 | positive regulation of chemokine secretion (GO:0090197) | 2.85949775 |
99 | apoptotic cell clearance (GO:0043277) | 2.84813463 |
100 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.84637945 |
101 | germinal center formation (GO:0002467) | 2.82709463 |
102 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.82562586 |
103 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 2.81260700 |
104 | cell adhesion mediated by integrin (GO:0033627) | 2.79722962 |
105 | myeloid dendritic cell activation (GO:0001773) | 2.79204682 |
106 | * lymphocyte chemotaxis (GO:0048247) | 2.78353952 |
107 | response to protozoan (GO:0001562) | 2.78272594 |
108 | regulation of cytokine secretion involved in immune response (GO:0002739) | 2.75666429 |
109 | protein localization to endosome (GO:0036010) | 2.74981246 |
110 | * positive regulation of leukocyte chemotaxis (GO:0002690) | 2.74695772 |
111 | cellular response to arsenic-containing substance (GO:0071243) | 2.74390151 |
112 | positive regulation of interleukin-6 production (GO:0032755) | 2.74366719 |
113 | positive regulation of nitric oxide biosynthetic process (GO:0045429) | 2.73455341 |
114 | I-kappaB phosphorylation (GO:0007252) | 2.71905005 |
115 | dendritic cell differentiation (GO:0097028) | 2.71366474 |
116 | mesenchymal-epithelial cell signaling (GO:0060638) | 2.70361437 |
117 | * positive regulation of leukocyte migration (GO:0002687) | 2.70252195 |
118 | fat-soluble vitamin biosynthetic process (GO:0042362) | 2.69358893 |
119 | phagosome maturation (GO:0090382) | 2.68913545 |
120 | regulation of interleukin-6 biosynthetic process (GO:0045408) | 2.67889591 |
121 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.67648535 |
122 | response to manganese ion (GO:0010042) | 2.66142950 |
123 | regulation of macrophage cytokine production (GO:0010935) | 2.66067511 |
124 | macrophage differentiation (GO:0030225) | 2.64854478 |
125 | ribosomal small subunit assembly (GO:0000028) | 2.64038629 |
126 | myeloid leukocyte activation (GO:0002274) | 2.63659963 |
127 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.63335351 |
128 | regulation of heat generation (GO:0031650) | 2.62701179 |
129 | * neutrophil chemotaxis (GO:0030593) | 2.62649751 |
130 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.61818831 |
131 | regulation of toll-like receptor 4 signaling pathway (GO:0034143) | 2.61027781 |
132 | positive regulation of leukocyte degranulation (GO:0043302) | 2.60670259 |
133 | response to thyroid hormone (GO:0097066) | 2.60246121 |
134 | negative regulation of lipid storage (GO:0010888) | 2.60163733 |
135 | positive regulation of astrocyte differentiation (GO:0048711) | 2.60157256 |
136 | positive regulation vascular endothelial growth factor production (GO:0010575) | 2.59454361 |
137 | regulation of macrophage differentiation (GO:0045649) | 2.58838852 |
138 | mRNA transcription (GO:0009299) | 2.58411967 |
139 | tyrosine phosphorylation of STAT protein (GO:0007260) | 2.58259622 |
140 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.57022720 |
141 | positive regulation of antigen processing and presentation (GO:0002579) | 2.56292185 |
142 | regulation of podosome assembly (GO:0071801) | 2.55149524 |
143 | * regulation of leukocyte chemotaxis (GO:0002688) | 2.54275381 |
144 | wound healing, spreading of epidermal cells (GO:0035313) | 2.53618031 |
145 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.53247968 |
146 | positive regulation of mast cell degranulation (GO:0043306) | 2.53247968 |
147 | response to interferon-alpha (GO:0035455) | 2.52837048 |
148 | regulation of heterotypic cell-cell adhesion (GO:0034114) | 2.50464746 |
149 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.50132795 |
150 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.49010938 |
151 | negative regulation of interleukin-12 production (GO:0032695) | 2.48543955 |
152 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.47524304 |
153 | negative regulation of mast cell activation (GO:0033004) | 2.47214767 |
Rank | Gene Set | Z-score |
---|---|---|
1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 6.50384352 |
2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.09118011 |
3 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 4.22907161 |
4 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 3.98545185 |
5 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.80906862 |
6 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.72790624 |
7 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.41466888 |
8 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 3.28759403 |
9 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.16861660 |
10 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.13517234 |
11 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.12381610 |
12 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.81478435 |
13 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.69198979 |
14 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.55511384 |
15 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.52524418 |
16 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.47505846 |
17 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.44730838 |
18 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.43322295 |
19 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.43279236 |
20 | VDR_24787735_ChIP-Seq_THP-1_Human | 2.30580860 |
21 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.02924411 |
22 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.99916736 |
23 | GATA1_22025678_ChIP-Seq_K562_Human | 1.91874643 |
24 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.85939839 |
25 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.85939839 |
26 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.85939839 |
27 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.85027306 |
28 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.83028733 |
29 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.82007454 |
30 | * CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.80345178 |
31 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.78874101 |
32 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.78874101 |
33 | CJUN_26792858_Chip-Seq_BT549_Human | 1.77147095 |
34 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.76579628 |
35 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.76365199 |
36 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.75999489 |
37 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.75713505 |
38 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.71635235 |
39 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.68854334 |
40 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.66382035 |
41 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.64406968 |
42 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.53181477 |
43 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.51593281 |
44 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.49331200 |
45 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.48718463 |
46 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.48474542 |
47 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.47943903 |
48 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.47838966 |
49 | * PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.47006947 |
50 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.44840621 |
51 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.41903807 |
52 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.41525850 |
53 | * ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.41145680 |
54 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.39575932 |
55 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.38672357 |
56 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.37318320 |
57 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.36530140 |
58 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.36102957 |
59 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.35999232 |
60 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.34813658 |
61 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.31471345 |
62 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.31209296 |
63 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.25338758 |
64 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.25338758 |
65 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.24176697 |
66 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.22440354 |
67 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.21677200 |
68 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.19315341 |
69 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.18515405 |
70 | * SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.18324843 |
71 | * SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.18257634 |
72 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.16492591 |
73 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.15419203 |
74 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.14066190 |
75 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.13411307 |
76 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.13212237 |
77 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.12666564 |
78 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.11662199 |
79 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.09613075 |
80 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.08845395 |
81 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.08732032 |
82 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.08687761 |
83 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.07965758 |
84 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.07500124 |
85 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.07061244 |
86 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.06820570 |
87 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.05488166 |
88 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.05438110 |
89 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.04964987 |
90 | SPI1_23127762_ChIP-Seq_K562_Human | 1.04641640 |
91 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.03455001 |
92 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.03294020 |
93 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.03289710 |
94 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.02534431 |
95 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.02300089 |
96 | GATA1_19941826_ChIP-Seq_K562_Human | 1.01412241 |
97 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.00256007 |
98 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.99243734 |
99 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.98017026 |
100 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.96689101 |
101 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.96068801 |
102 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.95207888 |
103 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.95018793 |
104 | MAF_26560356_Chip-Seq_TH1_Human | 0.94066525 |
105 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 0.93478685 |
106 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.93398168 |
107 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.91947432 |
108 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.91541029 |
109 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.91513233 |
110 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.91092368 |
111 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.90204609 |
112 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.89492418 |
113 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.89197127 |
114 | TP53_16413492_ChIP-PET_HCT116_Human | 0.88961684 |
115 | * SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.87243390 |
116 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.85008531 |
117 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.84579530 |
118 | BRD4_25478319_ChIP-Seq_HGPS_Human | 0.84430197 |
119 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.84303253 |
120 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.84214150 |
121 | MYB_26560356_Chip-Seq_TH2_Human | 0.84154716 |
122 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.84120017 |
123 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.83990607 |
124 | * NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.83692794 |
125 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.83451829 |
126 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.83178482 |
127 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.80052627 |
128 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.77100436 |
129 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.75777444 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0003436_decreased_susceptibility_to | 4.10091970 |
2 | MP0008438_abnormal_cutaneous_collagen | 4.02615647 |
3 | MP0003303_peritoneal_inflammation | 3.52427138 |
4 | * MP0002148_abnormal_hypersensitivity_rea | 3.50176995 |
5 | MP0003195_calcinosis | 3.44770470 |
6 | MP0002139_abnormal_hepatobiliary_system | 2.93087258 |
7 | MP0005058_abnormal_lysosome_morphology | 2.89813952 |
8 | MP0006082_CNS_inflammation | 2.78430018 |
9 | * MP0009785_altered_susceptibility_to | 2.76228241 |
10 | MP0000372_irregular_coat_pigmentation | 2.68147919 |
11 | MP0005167_abnormal_blood-brain_barrier | 2.56115579 |
12 | * MP0000343_altered_response_to | 2.54950336 |
13 | * MP0002419_abnormal_innate_immunity | 2.53848575 |
14 | * MP0005000_abnormal_immune_tolerance | 2.50774527 |
15 | MP0001533_abnormal_skeleton_physiology | 2.50228375 |
16 | MP0001835_abnormal_antigen_presentation | 2.43324937 |
17 | MP0005076_abnormal_cell_differentiation | 2.41291251 |
18 | MP0003705_abnormal_hypodermis_morpholog | 2.20777416 |
19 | * MP0005023_abnormal_wound_healing | 2.12496104 |
20 | MP0003279_aneurysm | 2.03876304 |
21 | MP0008004_abnormal_stomach_pH | 1.99517617 |
22 | * MP0005025_abnormal_response_to | 1.98028460 |
23 | MP0005275_abnormal_skin_tensile | 1.96916767 |
24 | MP0003724_increased_susceptibility_to | 1.95916496 |
25 | MP0004510_myositis | 1.95666376 |
26 | MP0005257_abnormal_intraocular_pressure | 1.94960219 |
27 | MP0003075_altered_response_to | 1.84486384 |
28 | MP0001790_abnormal_immune_system | 1.83755432 |
29 | MP0005387_immune_system_phenotype | 1.83755432 |
30 | * MP0002452_abnormal_antigen_presenting | 1.83290584 |
31 | MP0002998_abnormal_bone_remodeling | 1.82141123 |
32 | MP0010352_gastrointestinal_tract_polyps | 1.79283800 |
33 | MP0003806_abnormal_nucleotide_metabolis | 1.78146637 |
34 | MP0005390_skeleton_phenotype | 1.76531974 |
35 | MP0003448_altered_tumor_morphology | 1.70220162 |
36 | MP0005503_abnormal_tendon_morphology | 1.67319021 |
37 | * MP0002723_abnormal_immune_serum | 1.65793359 |
38 | * MP0009764_decreased_sensitivity_to | 1.63982816 |
39 | MP0005171_absent_coat_pigmentation | 1.63662998 |
40 | MP0005166_decreased_susceptibility_to | 1.59833320 |
41 | MP0004947_skin_inflammation | 1.58559907 |
42 | MP0001958_emphysema | 1.56405052 |
43 | MP0003300_gastrointestinal_ulcer | 1.55696145 |
44 | * MP0005164_abnormal_response_to | 1.53712645 |
45 | * MP0001800_abnormal_humoral_immune | 1.49110162 |
46 | * MP0001845_abnormal_inflammatory_respons | 1.48999045 |
47 | MP0001853_heart_inflammation | 1.48886993 |
48 | MP0003172_abnormal_lysosome_physiology | 1.47298545 |
49 | MP0002295_abnormal_pulmonary_circulatio | 1.43587614 |
50 | MP0000604_amyloidosis | 1.42153702 |
51 | MP0009384_cardiac_valve_regurgitation | 1.41040162 |
52 | MP0002405_respiratory_system_inflammati | 1.40148905 |
53 | MP0010155_abnormal_intestine_physiology | 1.40033333 |
54 | MP0005671_abnormal_response_to | 1.38783125 |
55 | * MP0008469_abnormal_protein_level | 1.38682528 |
56 | MP0005451_abnormal_body_composition | 1.34427374 |
57 | MP0003656_abnormal_erythrocyte_physiolo | 1.33525767 |
58 | * MP0001819_abnormal_immune_cell | 1.30475911 |
59 | MP0003191_abnormal_cellular_cholesterol | 1.29834700 |
60 | MP0003828_pulmonary_edema | 1.29531130 |
61 | * MP0002420_abnormal_adaptive_immunity | 1.29035521 |
62 | MP0003329_amyloid_beta_deposits | 1.28313618 |
63 | * MP0003690_abnormal_glial_cell | 1.26839662 |
64 | MP0002933_joint_inflammation | 1.24118542 |
65 | MP0002138_abnormal_hepatobiliary_system | 1.21431052 |
66 | MP0003950_abnormal_plasma_membrane | 1.20242079 |
67 | MP0003091_abnormal_cell_migration | 1.18493987 |
68 | * MP0000249_abnormal_blood_vessel | 1.18492031 |
69 | MP0005464_abnormal_platelet_physiology | 1.18253676 |
70 | MP0005508_abnormal_skeleton_morphology | 1.14364476 |
71 | MP0000858_altered_metastatic_potential | 1.12060941 |
72 | MP0002877_abnormal_melanocyte_morpholog | 1.09051207 |
73 | MP0004883_abnormal_blood_vessel | 1.08080723 |
74 | * MP0003795_abnormal_bone_structure | 1.06782389 |
75 | MP0009278_abnormal_bone_marrow | 1.06496655 |
76 | * MP0009840_abnormal_foam_cell | 1.04471104 |
77 | MP0009333_abnormal_splenocyte_physiolog | 1.03859766 |
78 | MP0003186_abnormal_redox_activity | 1.02366060 |
79 | MP0001542_abnormal_bone_strength | 0.99512144 |
80 | MP0002837_dystrophic_cardiac_calcinosis | 0.98764324 |
81 | MP0001243_abnormal_dermal_layer | 0.97576997 |
82 | MP0003453_abnormal_keratinocyte_physiol | 0.97237384 |
83 | MP0005623_abnormal_meninges_morphology | 0.97184225 |
84 | MP0002254_reproductive_system_inflammat | 0.95617924 |
85 | MP0010368_abnormal_lymphatic_system | 0.94283011 |
86 | MP0005165_increased_susceptibility_to | 0.92830041 |
87 | MP0002332_abnormal_exercise_endurance | 0.92549061 |
88 | MP0009763_increased_sensitivity_to | 0.91932962 |
89 | MP0001727_abnormal_embryo_implantation | 0.88366838 |
90 | MP0000371_diluted_coat_color | 0.85717599 |
91 | MP0008873_increased_physiological_sensi | 0.85287606 |
92 | MP0005310_abnormal_salivary_gland | 0.84771927 |
93 | MP0005365_abnormal_bile_salt | 0.83957351 |
94 | MP0001299_abnormal_eye_distance/ | 0.83583393 |
95 | MP0000685_abnormal_immune_system | 0.82220926 |
96 | MP0002277_abnormal_respiratory_mucosa | 0.82078030 |
97 | MP0002168_other_aberrant_phenotype | 0.81682924 |
98 | * MP0005197_abnormal_uvea_morphology | 0.81102615 |
99 | MP0008260_abnormal_autophagy | 0.77850851 |
100 | MP0006054_spinal_hemorrhage | 0.77646482 |
101 | MP0001851_eye_inflammation | 0.76744666 |
102 | MP0010307_abnormal_tumor_latency | 0.75706627 |
103 | * MP0005595_abnormal_vascular_smooth | 0.74893827 |
104 | * MP0000716_abnormal_immune_system | 0.74366439 |
105 | MP0000767_abnormal_smooth_muscle | 0.73575000 |
106 | MP0001663_abnormal_digestive_system | 0.73548820 |
107 | MP0003634_abnormal_glial_cell | 0.73517518 |
108 | MP0001849_ear_inflammation | 0.72825073 |
109 | MP0004272_abnormal_basement_membrane | 0.71985976 |
110 | MP0001545_abnormal_hematopoietic_system | 0.70940567 |
111 | MP0005397_hematopoietic_system_phenotyp | 0.70940567 |
112 | MP0000689_abnormal_spleen_morphology | 0.70659122 |
113 | * MP0002429_abnormal_blood_cell | 0.67026145 |
114 | MP0002060_abnormal_skin_morphology | 0.67003343 |
115 | MP0000465_gastrointestinal_hemorrhage | 0.66016720 |
116 | MP0003566_abnormal_cell_adhesion | 0.65959129 |
117 | MP0002896_abnormal_bone_mineralization | 0.65374817 |
118 | * MP0000920_abnormal_myelination | 0.64951477 |
119 | MP0002133_abnormal_respiratory_system | 0.64342045 |
120 | MP0005647_abnormal_sex_gland | 0.64216511 |
121 | MP0002090_abnormal_vision | 0.59324203 |
122 | MP0010386_abnormal_urinary_bladder | 0.58751144 |
123 | * MP0009765_abnormal_xenobiotic_induced | 0.58102561 |
124 | MP0002398_abnormal_bone_marrow | 0.57845308 |
125 | MP0005319_abnormal_enzyme/_coenzyme | 0.57766528 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Axonal loss (HP:0003447) | 5.90203598 |
2 | Recurrent abscess formation (HP:0002722) | 5.02355988 |
3 | Systemic lupus erythematosus (HP:0002725) | 5.00404886 |
4 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 4.52022765 |
5 | Loss of speech (HP:0002371) | 4.39558581 |
6 | Recurrent bacterial skin infections (HP:0005406) | 4.26402936 |
7 | Increased density of long bones (HP:0006392) | 4.18288303 |
8 | Neurofibrillary tangles (HP:0002185) | 4.13061933 |
9 | Mutism (HP:0002300) | 4.03848894 |
10 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.86563075 |
11 | Increased cerebral lipofuscin (HP:0011813) | 3.86239928 |
12 | Premature rupture of membranes (HP:0001788) | 3.81733854 |
13 | Eczematoid dermatitis (HP:0000976) | 3.73838972 |
14 | Protrusio acetabuli (HP:0003179) | 3.63043308 |
15 | Vertebral compression fractures (HP:0002953) | 3.60994136 |
16 | Nuclear cataract (HP:0100018) | 3.55843214 |
17 | Wrist flexion contracture (HP:0001239) | 3.44037820 |
18 | Glomerulonephritis (HP:0000099) | 3.35414064 |
19 | Autoimmune thrombocytopenia (HP:0001973) | 3.19851850 |
20 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 3.13619850 |
21 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 3.10844235 |
22 | Osteolytic defects of the hand bones (HP:0009699) | 3.10844235 |
23 | Pathologic fracture (HP:0002756) | 3.10566017 |
24 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.10282003 |
25 | Dysostosis multiplex (HP:0000943) | 3.09140072 |
26 | Soft skin (HP:0000977) | 3.08095842 |
27 | Disinhibition (HP:0000734) | 3.06866755 |
28 | Mesomelia (HP:0003027) | 3.05369181 |
29 | Vacuolated lymphocytes (HP:0001922) | 3.00701914 |
30 | Metaphyseal irregularity (HP:0003025) | 2.94780997 |
31 | Hypoplastic ischia (HP:0003175) | 2.92384699 |
32 | Cerebral inclusion bodies (HP:0100314) | 2.92332167 |
33 | Abnormality of complement system (HP:0005339) | 2.91580972 |
34 | Spontaneous hematomas (HP:0007420) | 2.91315733 |
35 | Peritonitis (HP:0002586) | 2.89407077 |
36 | Apathy (HP:0000741) | 2.86615095 |
37 | Abnormality of macrophages (HP:0004311) | 2.85729672 |
38 | Diminished motivation (HP:0000745) | 2.85119698 |
39 | Cervical subluxation (HP:0003308) | 2.81915653 |
40 | Poor head control (HP:0002421) | 2.81053758 |
41 | Prostate neoplasm (HP:0100787) | 2.81037642 |
42 | Reticulocytopenia (HP:0001896) | 2.80873895 |
43 | Complement deficiency (HP:0004431) | 2.75087725 |
44 | Fragile skin (HP:0001030) | 2.73790943 |
45 | Basal ganglia calcification (HP:0002135) | 2.64490654 |
46 | Atrophic scars (HP:0001075) | 2.61408438 |
47 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.58478044 |
48 | Pustule (HP:0200039) | 2.58028735 |
49 | J-shaped sella turcica (HP:0002680) | 2.56580438 |
50 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.53673768 |
51 | Long clavicles (HP:0000890) | 2.52888068 |
52 | Malnutrition (HP:0004395) | 2.51060029 |
53 | Neuronal loss in central nervous system (HP:0002529) | 2.50062791 |
54 | Optic neuritis (HP:0100653) | 2.49773206 |
55 | Abnormality of the ischium (HP:0003174) | 2.49145091 |
56 | Fibular aplasia (HP:0002990) | 2.47896395 |
57 | Obstructive lung disease (HP:0006536) | 2.46345723 |
58 | Chronic obstructive pulmonary disease (HP:0006510) | 2.46345723 |
59 | Myositis (HP:0100614) | 2.45371042 |
60 | Orchitis (HP:0100796) | 2.44832285 |
61 | Cerebral aneurysm (HP:0004944) | 2.44124904 |
62 | Sparse lateral eyebrow (HP:0005338) | 2.43379467 |
63 | Mediastinal lymphadenopathy (HP:0100721) | 2.43062111 |
64 | Myocardial infarction (HP:0001658) | 2.42143508 |
65 | Progressive neurologic deterioration (HP:0002344) | 2.40815303 |
66 | Inappropriate behavior (HP:0000719) | 2.40778179 |
67 | Chin dimple (HP:0010751) | 2.39190182 |
68 | Arterial tortuosity (HP:0005116) | 2.39068369 |
69 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 2.38465062 |
70 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.38342207 |
71 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.38342207 |
72 | Abnormality of glycolipid metabolism (HP:0010969) | 2.38342207 |
73 | Vascular tortuosity (HP:0004948) | 2.37760328 |
74 | Prolonged neonatal jaundice (HP:0006579) | 2.34593205 |
75 | Conjunctival telangiectasia (HP:0000524) | 2.33648810 |
76 | Upper motor neuron abnormality (HP:0002127) | 2.32620678 |
77 | Amyloidosis (HP:0011034) | 2.32449417 |
78 | Recurrent skin infections (HP:0001581) | 2.31886936 |
79 | Gingivitis (HP:0000230) | 2.31516933 |
80 | Osteomyelitis (HP:0002754) | 2.30346130 |
81 | Aortic dissection (HP:0002647) | 2.29434420 |
82 | Dilatation of the ascending aorta (HP:0005111) | 2.29398752 |
83 | Purpura (HP:0000979) | 2.27731165 |
84 | Abnormality of iron homeostasis (HP:0011031) | 2.27645480 |
85 | Bone pain (HP:0002653) | 2.27464506 |
86 | Petechiae (HP:0000967) | 2.26446098 |
87 | Abnormal number of erythroid precursors (HP:0012131) | 2.23796067 |
88 | Biconcave vertebral bodies (HP:0004586) | 2.22208607 |
89 | Spondylolisthesis (HP:0003302) | 2.21854430 |
90 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.18911717 |
91 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.17981080 |
92 | Mucopolysacchariduria (HP:0008155) | 2.17981080 |
93 | Asymmetric septal hypertrophy (HP:0001670) | 2.17218992 |
94 | Microglossia (HP:0000171) | 2.15251822 |
95 | Absent eyelashes (HP:0000561) | 2.13084614 |
96 | Dementia (HP:0000726) | 2.12516462 |
97 | Nephritis (HP:0000123) | 2.12337933 |
98 | Joint hemorrhage (HP:0005261) | 2.11823477 |
99 | Thick nail (HP:0001805) | 2.11432485 |
100 | Hepatosplenomegaly (HP:0001433) | 2.11368821 |
101 | Nausea (HP:0002018) | 2.09728431 |
102 | Pulmonary infiltrates (HP:0002113) | 2.07442701 |
103 | Premature loss of primary teeth (HP:0006323) | 2.07396484 |
104 | Abnormality of the periventricular white matter (HP:0002518) | 2.06513226 |
105 | Retinal atrophy (HP:0001105) | 2.05527830 |
106 | Supranuclear gaze palsy (HP:0000605) | 2.03666613 |
107 | Hemoptysis (HP:0002105) | 2.03655892 |
108 | Stomatitis (HP:0010280) | 2.02924754 |
109 | Tetraparesis (HP:0002273) | 2.02913289 |
110 | Periodontitis (HP:0000704) | 2.02524592 |
111 | Decreased subcutaneous fat (HP:0001002) | 2.01024576 |
112 | Aortic aneurysm (HP:0004942) | 1.98804618 |
113 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 1.98584564 |
114 | Agnosia (HP:0010524) | 1.97251923 |
115 | Blue sclerae (HP:0000592) | 1.96610596 |
116 | Alopecia of scalp (HP:0002293) | 1.95963152 |
117 | Increased serum ferritin (HP:0003281) | 1.95423426 |
118 | Ovoid vertebral bodies (HP:0003300) | 1.92712936 |
119 | Wormian bones (HP:0002645) | 1.91817734 |
120 | Bell-shaped thorax (HP:0001591) | 1.90757214 |
121 | Recurrent fungal infections (HP:0002841) | 1.90166063 |
122 | Acrocyanosis (HP:0001063) | 1.89938418 |
123 | Absent phalangeal crease (HP:0006109) | 1.89889437 |
124 | Hematochezia (HP:0002573) | 1.89756487 |
125 | Xanthomatosis (HP:0000991) | 1.89397033 |
126 | Interstitial pulmonary disease (HP:0006530) | 1.85102567 |
127 | Hydroxyprolinuria (HP:0003080) | 1.83120928 |
128 | Abnormality of proline metabolism (HP:0010907) | 1.83120928 |
129 | Increased CSF protein (HP:0002922) | 1.82290559 |
130 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.82278239 |
131 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.82278239 |
132 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.82278239 |
133 | Diplopia (HP:0000651) | 1.82198473 |
134 | Abnormality of binocular vision (HP:0011514) | 1.82198473 |
135 | Thin bony cortex (HP:0002753) | 1.81176944 |
136 | Broad face (HP:0000283) | 1.81164598 |
137 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.80823650 |
138 | Personality changes (HP:0000751) | 1.80790085 |
139 | Abnormality of the pericardium (HP:0001697) | 1.79874312 |
140 | Bruising susceptibility (HP:0000978) | 1.78745297 |
141 | Zonular cataract (HP:0010920) | 1.78088737 |
142 | Retrobulbar optic neuritis (HP:0100654) | 1.78035421 |
143 | Progressive visual loss (HP:0000529) | 1.76940096 |
144 | Esophageal varix (HP:0002040) | 1.76540652 |
145 | Polyneuropathy (HP:0001271) | 1.74684038 |
146 | Recurrent viral infections (HP:0004429) | 1.73774370 |
147 | Protuberant abdomen (HP:0001538) | 1.70781275 |
148 | Peripheral demyelination (HP:0011096) | 1.68717150 |
149 | Restrictive lung disease (HP:0002091) | 1.68691063 |
150 | Cardiomegaly (HP:0001640) | 1.67918059 |
151 | Joint stiffness (HP:0001387) | 1.67603751 |
152 | Abnormality of the nasal mucosa (HP:0000433) | 1.67522613 |
153 | Mucosal telangiectasiae (HP:0100579) | 1.65326271 |
154 | Recurrent pneumonia (HP:0006532) | 1.63797342 |
155 | Keratoconjunctivitis sicca (HP:0001097) | 1.63255535 |
156 | Vasculitis (HP:0002633) | 1.63026812 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MAP3K14 | 4.89460341 |
2 | BLK | 4.36891209 |
3 | SCYL2 | 3.83846507 |
4 | NME2 | 3.73976924 |
5 | MOS | 3.58253036 |
6 | TBK1 | 2.98179077 |
7 | PIM2 | 2.84687077 |
8 | TGFBR2 | 2.57808342 |
9 | ERN1 | 2.41072775 |
10 | MAP3K3 | 2.40923671 |
11 | TYK2 | 2.19370809 |
12 | TAOK2 | 2.16486648 |
13 | BMX | 2.08052675 |
14 | IKBKB | 1.98731499 |
15 | KIT | 1.98628542 |
16 | DDR2 | 1.93158459 |
17 | IKBKE | 1.91693554 |
18 | ACVR1B | 1.79483298 |
19 | NEK9 | 1.77279018 |
20 | CDC42BPA | 1.69818584 |
21 | ADRBK2 | 1.54255906 |
22 | FES | 1.49471320 |
23 | ABL2 | 1.46172075 |
24 | TAOK1 | 1.41193575 |
25 | GRK7 | 1.40354698 |
26 | EIF2AK2 | 1.34036181 |
27 | EPHB1 | 1.30626456 |
28 | CHUK | 1.29591270 |
29 | LATS2 | 1.24938360 |
30 | TRPM7 | 1.21464081 |
31 | CAMKK2 | 1.20164316 |
32 | MAP2K3 | 1.20106866 |
33 | PRPF4B | 1.17239887 |
34 | IRAK3 | 1.15430133 |
35 | CSK | 1.14220940 |
36 | PAK2 | 1.14209244 |
37 | IRAK4 | 1.12854495 |
38 | ERBB3 | 1.12749794 |
39 | ARAF | 1.11853641 |
40 | TTN | 1.11122876 |
41 | MAP3K13 | 1.11102420 |
42 | LMTK2 | 1.08551717 |
43 | TEC | 1.08385941 |
44 | RIPK4 | 1.08104103 |
45 | PAK6 | 1.06776174 |
46 | MATK | 1.04828055 |
47 | HCK | 1.02280200 |
48 | JAK1 | 1.02277099 |
49 | LYN | 1.00906094 |
50 | TYRO3 | 0.97080122 |
51 | TXK | 0.96256394 |
52 | MAP3K9 | 0.90689763 |
53 | STK10 | 0.86974256 |
54 | ABL1 | 0.83934195 |
55 | BMPR2 | 0.82250773 |
56 | ITK | 0.80121704 |
57 | PTK2B | 0.79288374 |
58 | PBK | 0.79092685 |
59 | CAMK1D | 0.78134073 |
60 | TESK1 | 0.77296190 |
61 | DAPK3 | 0.77118673 |
62 | JAK3 | 0.76957108 |
63 | LIMK1 | 0.76202709 |
64 | STK24 | 0.74327656 |
65 | MAP2K2 | 0.73739007 |
66 | TGFBR1 | 0.73349920 |
67 | MAPK4 | 0.72403488 |
68 | PRKCD | 0.72264469 |
69 | PIM1 | 0.71100648 |
70 | MAP3K5 | 0.69491405 |
71 | SYK | 0.66733954 |
72 | EPHB2 | 0.66595931 |
73 | EGFR | 0.66054275 |
74 | LCK | 0.66009810 |
75 | CASK | 0.64487797 |
76 | MAP4K1 | 0.64183923 |
77 | RIPK1 | 0.63213910 |
78 | ZAP70 | 0.62399312 |
79 | MST1R | 0.61108171 |
80 | FGR | 0.60767654 |
81 | PDGFRB | 0.58907136 |
82 | GSK3A | 0.58770880 |
83 | MKNK1 | 0.57898888 |
84 | PAK4 | 0.55438361 |
85 | KSR2 | 0.55180761 |
86 | IRAK2 | 0.55174056 |
87 | MARK3 | 0.54980485 |
88 | PDGFRA | 0.54954980 |
89 | BTK | 0.54933311 |
90 | RPS6KC1 | 0.54580067 |
91 | RPS6KL1 | 0.54580067 |
92 | CLK1 | 0.54373593 |
93 | MAPKAPK5 | 0.52839407 |
94 | EPHA3 | 0.51529645 |
95 | PAK1 | 0.51191933 |
96 | RPS6KA4 | 0.50072635 |
97 | INSR | 0.49657453 |
98 | ERBB4 | 0.49484694 |
99 | MAP2K1 | 0.48312449 |
100 | CDK6 | 0.46810456 |
101 | EPHA2 | 0.46765266 |
102 | PIK3CG | 0.46134143 |
103 | IRAK1 | 0.45866640 |
104 | JAK2 | 0.43958780 |
105 | PRKG2 | 0.43646561 |
106 | ADRBK1 | 0.43231258 |
107 | IGF1R | 0.42675774 |
108 | PDK2 | 0.42475673 |
109 | DAPK2 | 0.41909887 |
110 | RPS6KA2 | 0.41782422 |
111 | CAMK2D | 0.40244650 |
112 | CSF1R | 0.39383264 |
113 | GRK5 | 0.39306512 |
114 | LRRK2 | 0.38319052 |
115 | MAP2K6 | 0.38167377 |
116 | FYN | 0.37467317 |
117 | MAP3K12 | 0.37349077 |
118 | PDPK1 | 0.37297668 |
119 | MET | 0.34269280 |
120 | PTK6 | 0.31647653 |
121 | TESK2 | 0.30962631 |
122 | NUAK1 | 0.30755779 |
123 | RPS6KA6 | 0.30624242 |
124 | MAPK7 | 0.30210851 |
125 | PTK2 | 0.29850859 |
126 | MAP3K1 | 0.29343378 |
127 | DYRK1B | 0.29152631 |
128 | PRKD1 | 0.28426857 |
129 | MAP3K11 | 0.27519030 |
130 | SIK3 | 0.25626905 |
131 | CAMK1G | 0.25610225 |
132 | TAOK3 | 0.24962089 |
133 | MYLK | 0.24029251 |
134 | CAMK2G | 0.22020413 |
135 | PDK1 | 0.21436359 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.51692569 |
2 | Legionellosis_Homo sapiens_hsa05134 | 3.28263316 |
3 | * Malaria_Homo sapiens_hsa05144 | 3.07978159 |
4 | Leishmaniasis_Homo sapiens_hsa05140 | 3.05696201 |
5 | * Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.76617620 |
6 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.68819361 |
7 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.33565910 |
8 | Lysosome_Homo sapiens_hsa04142 | 2.31269480 |
9 | Pertussis_Homo sapiens_hsa05133 | 2.20781230 |
10 | Tuberculosis_Homo sapiens_hsa05152 | 2.11091355 |
11 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.08333247 |
12 | Salmonella infection_Homo sapiens_hsa05132 | 2.05534805 |
13 | * Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 2.04114378 |
14 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.01490668 |
15 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.01011358 |
16 | * TNF signaling pathway_Homo sapiens_hsa04668 | 2.00818902 |
17 | Phagosome_Homo sapiens_hsa04145 | 2.00648044 |
18 | * NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.87505168 |
19 | Asthma_Homo sapiens_hsa05310 | 1.78652869 |
20 | Allograft rejection_Homo sapiens_hsa05330 | 1.75695760 |
21 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.69136945 |
22 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.66317747 |
23 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.53686443 |
24 | Ribosome_Homo sapiens_hsa03010 | 1.52368756 |
25 | * Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.51616661 |
26 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.48130146 |
27 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.41780853 |
28 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.41453371 |
29 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.39212857 |
30 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.38511846 |
31 | Amoebiasis_Homo sapiens_hsa05146 | 1.37513901 |
32 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.36721394 |
33 | * Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.33691232 |
34 | Apoptosis_Homo sapiens_hsa04210 | 1.32397637 |
35 | Other glycan degradation_Homo sapiens_hsa00511 | 1.21583007 |
36 | Measles_Homo sapiens_hsa05162 | 1.20765159 |
37 | Shigellosis_Homo sapiens_hsa05131 | 1.18649041 |
38 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.15829484 |
39 | Prion diseases_Homo sapiens_hsa05020 | 1.15192909 |
40 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.12541029 |
41 | * AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.09754715 |
42 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.09008409 |
43 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.08409898 |
44 | * Influenza A_Homo sapiens_hsa05164 | 1.07331549 |
45 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.06770552 |
46 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.06465907 |
47 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.05324744 |
48 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.04889017 |
49 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.04657378 |
50 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.04195621 |
51 | Viral myocarditis_Homo sapiens_hsa05416 | 1.00932510 |
52 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.98905054 |
53 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.98323266 |
54 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.96756529 |
55 | Mineral absorption_Homo sapiens_hsa04978 | 0.96148121 |
56 | Hepatitis B_Homo sapiens_hsa05161 | 0.92640867 |
57 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.91793028 |
58 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.90565285 |
59 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.89725295 |
60 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.89401690 |
61 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.85082948 |
62 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.84371394 |
63 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.82374159 |
64 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.75518109 |
65 | Melanoma_Homo sapiens_hsa05218 | 0.74437522 |
66 | Focal adhesion_Homo sapiens_hsa04510 | 0.73295830 |
67 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.67388625 |
68 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.66841094 |
69 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.66442326 |
70 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.66028842 |
71 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.65324411 |
72 | Galactose metabolism_Homo sapiens_hsa00052 | 0.64582925 |
73 | Hepatitis C_Homo sapiens_hsa05160 | 0.63903012 |
74 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.63305207 |
75 | * Herpes simplex infection_Homo sapiens_hsa05168 | 0.61040446 |
76 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.59530611 |
77 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.54392037 |
78 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.54224799 |
79 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.53397517 |
80 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.53384660 |
81 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.53193252 |
82 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.50569201 |
83 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.49850613 |
84 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.48340434 |
85 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.47218802 |
86 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.46677129 |
87 | Platelet activation_Homo sapiens_hsa04611 | 0.45926330 |
88 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.45765642 |
89 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.45330027 |
90 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.39799072 |
91 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.39463742 |
92 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.38772553 |
93 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.37440742 |
94 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.37281058 |
95 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.36173138 |
96 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.35694704 |
97 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.35628308 |
98 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.35548577 |
99 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.35261441 |
100 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.34048828 |
101 | Bladder cancer_Homo sapiens_hsa05219 | 0.33312304 |
102 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.33287722 |
103 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.33034271 |
104 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.32761342 |
105 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.31692451 |
106 | HTLV-I infection_Homo sapiens_hsa05166 | 0.31060429 |
107 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.29444265 |
108 | Prostate cancer_Homo sapiens_hsa05215 | 0.29407812 |
109 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.29195402 |
110 | Endocytosis_Homo sapiens_hsa04144 | 0.28646031 |
111 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.28406149 |
112 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.28153540 |
113 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.27791811 |
114 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.27713900 |
115 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.25805201 |
116 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.25709267 |
117 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.20663742 |
118 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.20321619 |
119 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.19548267 |
120 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.17526042 |
121 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.13474147 |
122 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.12044812 |
123 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.10319838 |